Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Andrographis Paniculata in Advanced Esophageal Cancer
NCT04196075Phase 3Completed
- Sponsor
- The Chinese University of Hong Kong
- Start
- Mar 2018
- Primary completion
- Feb 2021
- Modality
- HM (Herbal Medicine)
- Countries
- 1
01
Overview
A Phase 3 trial of andrographis paniculata in Esophageal Squamous Cell Carcinoma (ESCC), sponsored by The Chinese University of Hong Kong. Started Mar 2018; status: completed.
02
Drugs
andrographis paniculata
03
Conditions
Esophageal Squamous Cell Carcinoma (ESCC)
Beyond the preview
Go deeper on NCT04196075.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04196075.